Ac immune to present at the jefferies 2023 cns & neuro summit in october 2023

Ac immune to present at the jefferies 2023 cns & neuro summit in october 2023 lausanne, switzerland, october 5, 2023 – ac immune sa (nasdaq: aciu), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that company management will present a corporate overview and participate in one-on-one investor meetings during the jefferies 2023 cns & neuro summit, taking place in-person in new york city on october 11-12, 2023. ac immune's corporate presentation will be given in-person with q&a on thursday, october 12 at 8:00 am (edt) / 2:00 pm (cest) and will also be accessible via the conference platform.
ACIU Ratings Summary
ACIU Quant Ranking